Audit 323278

FY End
2023-12-31
Total Expended
$18.81M
Findings
0
Programs
12
Organization: Sage Bionetworks (WA)
Year: 2023 Accepted: 2024-09-30
Auditor: Clark Nuber P S

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.838 Lung Diseases Resarch $3.04M Yes 0
93.396 Cancer Biology Research $1.85M Yes 0
93.353 21st Century Cures Act Beau Biden Cancer Moonshot $1.16M Yes 0
93.310 Transnih Research Support $337,064 Yes 0
93.242 Mental Health Research Grants $153,409 Yes 0
93.866 Aging Research $152,245 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $125,451 Yes 0
93.879 Medical Library Assistance $82,197 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $39,126 Yes 0
93.837 Cardiovascular Diseases Research $27,533 Yes 0
93.350 National Center for Advancing Translational Sciences $2,747 Yes 0
93.395 Cancer Treatment Research $2,353 Yes 0

Contacts

Name Title Type
TPALZA9N4M11 Brandon Morgan Auditee
2069288251 Candice Avery Auditor
No contacts on file

Notes to SEFA

Title: Note 1 - Method of Accounting Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Organization has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The Organization has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal award activity of Sage Bionetworks (the Organization) under programs of the federal government for the year ended December 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Organization, it is not intended to and does not present the financial position, changes in net assets, functional expenses, or cash flows of the Organization.
Title: Note 2 - Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Organization has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: The Organization has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Organization has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.